Erez Kalir

CIK: 0001512447

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

VOR

Vor Biopharma Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (3 total)

VOR
Vor Biopharma Inc.
Jun 11, 2026
Award(A)
Stock Option (right to buy)
Direct
57.2K shares-
VOR
Vor Biopharma Inc.
May 22, 2025
Award(A)
Stock Option (Right to Buy)
Direct
30K shares-
VOR
Vor Biopharma Inc.
Jan 6, 2025
Award(A)
Stock Option (right to buy)
Direct
60K shares-

		Type	Shares	Price		Ownership
Jun 11, 2026	VOR Vor Biopharma Inc.	Award(A) Stock Option (right to buy)	57,162	-	-	Direct
May 22, 2025	VOR Vor Biopharma Inc.	Award(A) Stock Option (Right to Buy)	30,000	-	-	Direct
Jan 6, 2025	VOR Vor Biopharma Inc.	Award(A) Stock Option (right to buy)	60,000	-	-	Direct

1-3 of 3 transactions

About Kalir Erez

Kalir Erez (SEC CIK 0001512447) files insider reports with the SEC as Director of Vor Biopharma Inc. (VOR).

Signal8 holds 4 ownership filings by Kalir Erez (1 Form 3, 3 Form 4), filed between Jan 8, 2025 and Jun 12, 2026. Those filings report 3 transactions, from Jan 6, 2025 to Jun 11, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Kalir Erez's filings is in BOSTON, MA.

Recent filings by Kalir Erez

Jun 11, 2026: Grant or award of VOR derivative securities (Form 4, code A).
May 22, 2025: Grant or award of VOR derivative securities (Form 4, code A).
Jan 6, 2025: Grant or award of VOR derivative securities (Form 4, code A).

Other insiders filing for Vor Biopharma Inc. (VOR)

How to read Form 4 transaction codes